Europe Dry Eye Syndrome Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Oct 2021
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Dry Eye Syndrome Market, By Type (Evaporative, Aqueous), Product (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type(Liquid, Gel, Ointment, Others), Drug Class (Lubricating Agents, Cholinergic, Anti-Inflammatory, Anti-Infective, Anti-Allergic, Others), Dose (Unit dose, Multi-dose), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type( Unit-Dose Vials, Bottles, Tubes), Packaging Type (Plastic, Aluminum, Glass), Category (Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe) Industry Trends and Forecast to 2028.

Europe Dry Eye Syndrome Market Market Analysis and Insights : Europe Dry Eye Syndrome Market

Dry eye syndrome market size is projected to grow at a compound annual growth rate of 5.9% over the forecast period of 2021 to 2028. Data Bridge Market Research report on dry eye syndrome market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth.

Dry eye syndrome (also referred as keratoconjunctivitis sicca or KCS), is a multifactorial disease that occurs due to the lack of lubrication or moisture on the surface of the infected person’s eyes, which might make possible damage to the ocular surface. It is a commonly occurring disease which can affect almost anyone, which can be caused due to excessive computer uses, allergies, LASIK eye surgery, aging, menopause, smoking or hormone replacement therapy among others. Its symptoms include watery eyes, photophobia, eye redness, sore eyes, stinging burning, eye fatigue, blurred vision and scratchy sensation in eyes.

The rising geriatric population and rapid rise in prevalence of diseases such as Sjogren’s syndrome, diabetes, thyroid disorders, scleroderma, rheumatoid arthritis and lupus among others also result in dry eyes which is expected to accelerate the market growth. Additionally, rising diagnostic rates, increasing awareness levels regarding dry eye syndrome and presence of better and advanced treatment options will further carve the way for the growth of the market. However, the factors such as high cost of specialty dry eye products and availability of alternative therapies across the globe is projected to restrain the market growth rate. The complex reimbursement scenario also hampers the market’s growth rate in the forecast period of 2021 to 2028.

In addition, the increasing investment in the research and development of treatment options associated with this disease are likely to create various new opportunities that will impact this dry eye syndrome market growth in the forecast period of 2021 to 2028.The lockdown due to COVID-19 pandemic led to disruption of healthcare systems, which is estimated to challenge the market’s growth.

This dry eye syndrome market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the dry eye syndrome market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Dry Eye Syndrome Market Scope and Market Size

Dry eye syndrome market is segmented on the basis of type, product, dosage type, drug class, dose, medication type, container type, packaging type, category, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the market is segmented into evaporative and aqueous.
  • On the basis of product, the market is segmented into tear stimulators, artificial tears, secretagogue and others.
  • On the basis of dosage type, the dry eye syndrome market is segmented into liquid, gel, ointment and others.
  • On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infective, anti-allergic, cholinergic and others.
  • On the basis of dose, the dry eye syndrome market is segregated into multi dose and unit dose.
  • On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs.
  • On the basis of container type, the dry eye syndrome market is segmented into unit dose vials, bottles, and tubes.
  • On the basis of packaging type, the market is segmented into plastic, glass, and aluminum.
  • On the basis of category, the dry eye syndrome market is segmented into generics and brands.
  • On the basis of end user, the market is bifurcated into home healthcare, hospitals, clinics, and others.
  • On the basis of distribution channel, the dry eye syndrome market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

Dry Eye Syndrome Market Country Level Analysis

Dry eye syndrome market is segmented on the basis of type, product, dosage type, drug class, dose, medication type, container type, packaging type, category, end user and distribution channel.

The countries covered in the dry eye syndrome market report are Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland and rest of Europe in Europe.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Dry eye syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Europe Dry Eye Syndrome Market Share Analysis

Dry eye syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to dry eye syndrome market.

The major players covered in the dry eye syndrome market report are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Private Limited., Prestige Consumer Healthcare, Inc., Akorn Operating Company LLC., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx Ltd, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Europe Dry Eye Syndrome Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions